CAR T-Cell Therapy and Blood Cancers

Topics Covered

We invite you to learn more about:

• Advances in CAR T-cell (chimeric antigen receptor T cell) therapy for blood cancers
• Which blood cancers benefit from CAR T-cell therapy
• Approved and emerging CAR T-cell therapies
• When to ask your doctor if CAR T-cell therapy is right for you

Program Materials

Speaker

Keren Osman, MD
Associate Professor
Director, Cellular Therapy Service
Bone Marrow and Stem Cell Transplant
Tisch Cancer Institute
Mount Sinai School of Medicine
New York, NY
 

Program Support

Support for this program is provided by Allogene Therapeutics; Bristol Myers Squibb; CRISPR Therapeutics; Janssen Oncology & Legend Biotech; Kite, A Gilead Company; and Novartis Oncology.

< Back to Webcasts